Literature DB >> 15177116

Gene expression profiling of bovine macrophages in response to Escherichia coli O157:H7 lipopolysaccharide.

Carol G Chitko-McKown1, James M Fox, Laura C Miller, Michael P Heaton, James L Bono, James E Keen, William M Grosse, William W Laegreid.   

Abstract

The aim of this study was to identify changes in bovine macrophage gene expression in response to treatment with Escherichia coli 0157:H7 lipopolysaccharide (LPS), utilizing a human gene microarray. Bovine cDNA from control and LPS-treated primary macrophages hybridized to greater than 5644 (79.8%) of the non-control gene targets on a commercially available microarray containing greater than 7075 targets (Incyte Genomics, St. Louis, MO). Of these target sequences, 44 were differentially expressed upon exposure to LPS, including 18 genes not previously reported to exist in cattle. These included a pentaxin-related gene, CASP8, TNF-induced genes, interferon-induced genes, and inhibitors of apoptosis. Using the human microarray, cDNA from bovine LPS-treated and control macrophages consistently hybridized to targets known to be expressed constitutively by macrophages, as expected given the predicted cDNA sequence homology. That this human system was accurately estimating levels of bovine transcripts was further verified by real-time quantitative reverse transcriptase polymerase chain reaction (RTQ-PCR) using bovine-specific primers. This first report of bovine-human cross-species expression profiling by microarray hybridization demonstrates the utility of this technique in bovine gene expression and discovery.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15177116     DOI: 10.1016/j.dci.2003.10.002

Source DB:  PubMed          Journal:  Dev Comp Immunol        ISSN: 0145-305X            Impact factor:   3.636


  8 in total

1.  Development and characterization of two porcine monocyte-derived macrophage cell lines.

Authors:  Carol G Chitko-McKown; Stephen K Chapes; Laura C Miller; Penny K Riggs; M Teresa Ortega; Benedict T Green; Richard D McKown
Journal:  Results Immunol       Date:  2013

Review 2.  Advances in the development of enterohemorrhagic Escherichia coli vaccines using murine models of infection.

Authors:  Victor A Garcia-Angulo; Anjana Kalita; Alfredo G Torres
Journal:  Vaccine       Date:  2013-05-22       Impact factor: 3.641

3.  Construction and validation of a Bovine Innate Immune Microarray.

Authors:  Laurelea Donaldson; Tony Vuocolo; Christian Gray; Ylva Strandberg; Antonio Reverter; Sean McWilliam; Yonghong Wang; Keren Byrne; Ross Tellam
Journal:  BMC Genomics       Date:  2005-09-22       Impact factor: 3.969

4.  Derivation of species-specific hybridization-like knowledge out of cross-species hybridization results.

Authors:  Carmiya Bar-Or; Meira Bar-Eyal; Tali Z Gal; Yoram Kapulnik; Henryk Czosnek; Hinanit Koltai
Journal:  BMC Genomics       Date:  2006-05-08       Impact factor: 3.969

5.  Development and validation of a bovine macrophage specific cDNA microarray.

Authors:  Kirsty Jensen; Richard Talbot; Edith Paxton; David Waddington; Elizabeth J Glass
Journal:  BMC Genomics       Date:  2006-09-01       Impact factor: 3.969

6.  Characterization of ovine hepatic gene expression profiles in response to Escherichia coli lipopolysaccharide using a bovine cDNA microarray.

Authors:  Honghe Cao; Leah C Kabaroff; Qiumei You; Alexander Rodriguez; Herman J Boermans; Niel A Karrow
Journal:  BMC Vet Res       Date:  2006-11-29       Impact factor: 2.741

7.  A bovine CD18 signal peptide variant with increased binding activity to Mannheimia hemolytica leukotoxin.

Authors:  Aspen M Workman; Carol G Chitko-McKown; Timothy P L Smith; Gary L Bennett; Theodore S Kalbfleisch; Veronica Basnayake; Michael P Heaton
Journal:  F1000Res       Date:  2018-12-28

8.  Evaluation of suitable reference genes for gene expression studies in bovine muscular tissue.

Authors:  Raquel Pérez; Isabel Tupac-Yupanqui; Susana Dunner
Journal:  BMC Mol Biol       Date:  2008-09-11       Impact factor: 2.946

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.